Beatriz García-Paredes

First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)

Alfredo Carrato, Albert Abad, Bartomeu Massutí et al. · European Journal of Cancer · 2017 · 88 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial

Enrique Aranda, José María Viéitez, Auxiliadora Gómez‐España et al. · ESMO Open · 2020 · 61 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

<i><scp>BRCA2</scp></i> gene: a candidate for clinical testing in familial colorectal cancer type X

Pilar Garré, Atocha Romero, Alicia Tosar et al. · Clinical Genetics · 2014 · 43 citations

Life Sciences, Genetics, Molecular Genetics +17

Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling

Miguel Martín, Julio César de la Torre Montero, Sara López‐Tarruella et al. · Breast Cancer Research and Treatment · 2018 · 39 citations · Full text

Medicine, Dermatology, Oncology +15

A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck

Silvia Vázquez, Juan J. Grau, José Á. García-Sáenz et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 29 citations

Medicine, Oncology, Cancer Pharmacology +13